UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multimodal Prediction of Alzheimer's Disease Severity Level Based on Resting-State EEG and Structural MRI

Frontiers in human neuroscience, 2021-09, Vol.15, p.700627-700627

2021

Volltextzugriff (PDF)

Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress

Neuropharmacology, 2002-12, Vol.43 (7), p.1139-1147

2002

Volltextzugriff (PDF)

Use of Event Related Potential Markers in Patients with Traumatic Brain Injury (P6.305)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level

The Journal of neuroscience, 1999-12, Vol.19 (23), p.10494-10501

1999

Volltextzugriff (PDF)

Reactivity and synthetic applications of 4,5-dicyanopyridazine: an overview

Molecules, 2010-03, Vol.15 (3), p.1722-1745

2010

Volltextzugriff (PDF)

Use of event related potential markers in patients with traumatic brain injury

Neurology, 2018-12, Vol.91 (23_Supplement_1)

2018

Volltextzugriff (PDF)

Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress

Life sciences (1973), 2003-06, Vol.73 (6), p.715-726

2003

Volltextzugriff (PDF)

The gLite Workload Management System

Journal of physics. Conference series, 2010-04, Vol.219 (6), p.062039, Article 062039

2010

Volltextzugriff (PDF)

Event Related Potentials as a Prognostic Measure: Predictive Value for Rate of Cognitive Decline in Patients with Mild Alzheimer’s Disease. (P4.181)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

NEUROPSYCHOLOGICAL AND NEUROANATOMICAL CORRELATES OF EVENT-RELATED POTENTIALS IN PATIENTS WITH ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P772-P772

2017

Volltextzugriff (PDF)

Towards automated electroencephalography-based Alzheimer’s disease diagnosis using portable low-density devices

Biomedical signal processing and control, 2017-03, Vol.33, p.261-271

2017

Volltextzugriff (PDF)

Human capital development: perspectives of an expatriate hotel manager in Africa

Worldwide hospitality and tourism themes, 2016-04, Vol.8 (2), p.207-210

2016

Volltextzugriff (PDF)

PROGNOSTIC VALUE OF EVENT-RELATED POTENTIALS FOR RATE OF COGNITIVE DECLINE IN PATIENTS WITH MILD ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P1180-P1180

2018

Volltextzugriff (PDF)

P3‐269: PROGNOSTIC VALUE OF EVENT‐RELATED POTENTIALS FOR RATE OF COGNITIVE DECLINE IN PATIENTS WITH MILD ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_22)

2018

Volltextzugriff (PDF)

P3‐269: PROGNOSTIC VALUE OF EVENT‐RELATED POTENTIALS FOR RATE OF COGNITIVE DECLINE IN PATIENTS WITH MILD ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_22), p.P1180-P1180

2018

Volltextzugriff (PDF)

P2‐364: NEUROANATOMICAL AND NEUROPSYCHOLOGICAL CORRELATES OF RESTING STATE EEG DIAGNOSTIC FEATURES IN PATIENTS WITH ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_14), p.P739-P740

2019

Volltextzugriff (PDF)

NEUROANATOMICAL AND NEUROPSYCHOLOGICAL CORRELATES OF RESTING STATE EEG DIAGNOSTIC FEATURES IN PATIENTS WITH ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P739-P740

2019

Volltextzugriff (PDF)

EVALUATION OF EVENT RELATED POTENTIALS AND QUANTITATIVE EEG AS USEFUL BIOMARKERS FOR THE DIAGNOSIS OF EARLY-STAGE ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P236-P236

2014

Volltextzugriff (PDF)

New exploratory Alzheimer’s drug anavex 2-73 changes in electrophysiological markers in Alzheimer’s disease: First patient data from an ongoing phase 2a study in mild-to-moderate Alzheimer’s patients

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P900-P900

2015

Volltextzugriff (PDF)

P4‐300: New exploratory Alzheimer's drug anavex 2‐73 changes in electrophysiological markers in Alzheimer's disease: First patient data from an ongoing phase 2a study in mild‐to‐moderate Alzheimer's patients

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_19), p.P900-P900

2015

Volltextzugriff (PDF)

Development of a First Prototype of a Liquid-shaded Dynamic Glazed Facade for Buildings

Procedia engineering, 2014, Vol.85, p.94-103

2014

Volltextzugriff (PDF)

Serotonergic modulation of acetylcholine release from cortex of freely moving rats

The Journal of pharmacology and experimental therapeutics, 1998-06, Vol.285 (3), p.1219

1998

Volltextzugriff (PDF)

P1‐046: New Exploratory Alzheimer’S Drug Anavex 2‐73: Dose Dependent Clinical Cognitive Improvement Observed in Mini Mental State Examination (MMSE) and Other Cognitive Markers in a Phase 2A Study in Mild‐to‐Moderate Alzheimer’s Patients

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_8), p.P419-P419

2016

Volltextzugriff (PDF)

P4‐356: Safety and Efficacy 31 Week Data of Anavex 2‐73 in a Phase 2A Study in Mild‐Moderate Alzheimer’S Disease Patients

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_24), p.P1174-P1174

2016

Volltextzugriff (PDF)

SAFETY AND EFFICACY 31 WEEK DATA OF ANAVEX 2-73 IN A PHASE 2A STUDY IN MILD-MODERATE ALZHEIMER’S DISEASE PATIENTS

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P1174-P1174

2016

Volltextzugriff (PDF)

1 – 25 von 360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(318)

Publikationsform

Sprache

Englisch
(358)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Multimodal Prediction of Alzheimer's Disease Severity Level Based on Resting-State EEG and Structural MRI

Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress

Use of Event Related Potential Markers in Patients with Traumatic Brain Injury (P6.305)

Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level

Reactivity and synthetic applications of 4,5-dicyanopyridazine: an overview

Use of event related potential markers in patients with traumatic brain injury

Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress

The gLite Workload Management System

Event Related Potentials as a Prognostic Measure: Predictive Value for Rate of Cognitive Decline in Patients with Mild Alzheimer’s Disease. (P4.181)

NEUROPSYCHOLOGICAL AND NEUROANATOMICAL CORRELATES OF EVENT-RELATED POTENTIALS IN PATIENTS WITH ALZHEIMER’S DISEASE

Towards automated electroencephalography-based Alzheimer’s disease diagnosis using portable low-density devices

Human capital development: perspectives of an expatriate hotel manager in Africa

PROGNOSTIC VALUE OF EVENT-RELATED POTENTIALS FOR RATE OF COGNITIVE DECLINE IN PATIENTS WITH MILD ALZHEIMER’S DISEASE

P3‐269: PROGNOSTIC VALUE OF EVENT‐RELATED POTENTIALS FOR RATE OF COGNITIVE DECLINE IN PATIENTS WITH MILD ALZHEIMER'S DISEASE

P3‐269: PROGNOSTIC VALUE OF EVENT‐RELATED POTENTIALS FOR RATE OF COGNITIVE DECLINE IN PATIENTS WITH MILD ALZHEIMER'S DISEASE

P2‐364: NEUROANATOMICAL AND NEUROPSYCHOLOGICAL CORRELATES OF RESTING STATE EEG DIAGNOSTIC FEATURES IN PATIENTS WITH ALZHEIMER'S DISEASE

NEUROANATOMICAL AND NEUROPSYCHOLOGICAL CORRELATES OF RESTING STATE EEG DIAGNOSTIC FEATURES IN PATIENTS WITH ALZHEIMER’S DISEASE

EVALUATION OF EVENT RELATED POTENTIALS AND QUANTITATIVE EEG AS USEFUL BIOMARKERS FOR THE DIAGNOSIS OF EARLY-STAGE ALZHEIMER'S DISEASE

New exploratory Alzheimer’s drug anavex 2-73 changes in electrophysiological markers in Alzheimer’s disease: First patient data from an ongoing phase 2a study in mild-to-moderate Alzheimer’s patients

P4‐300: New exploratory Alzheimer's drug anavex 2‐73 changes in electrophysiological markers in Alzheimer's disease: First patient data from an ongoing phase 2a study in mild‐to‐moderate Alzheimer's patients

Development of a First Prototype of a Liquid-shaded Dynamic Glazed Facade for Buildings

Serotonergic modulation of acetylcholine release from cortex of freely moving rats

P1‐046: New Exploratory Alzheimer’S Drug Anavex 2‐73: Dose Dependent Clinical Cognitive Improvement Observed in Mini Mental State Examination (MMSE) and Other Cognitive Markers in a Phase 2A Study in Mild‐to‐Moderate Alzheimer’s Patients

P4‐356: Safety and Efficacy 31 Week Data of Anavex 2‐73 in a Phase 2A Study in Mild‐Moderate Alzheimer’S Disease Patients

SAFETY AND EFFICACY 31 WEEK DATA OF ANAVEX 2-73 IN A PHASE 2A STUDY IN MILD-MODERATE ALZHEIMER’S DISEASE PATIENTS

Suchergebnisse filtern